These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19243853)

  • 1. Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification.
    Huang YH; Wu JC; Peng WL; Huo TI; Shih HH; Lan KH; Su CW; Lee SD
    J Hepatol; 2009 Apr; 50(4):779-88. PubMed ID: 19243853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.
    Nisini R; Paroli M; Accapezzato D; Bonino F; Rosina F; Santantonio T; Sallusto F; Amoroso A; Houghton M; Barnaba V
    J Virol; 1997 Mar; 71(3):2241-51. PubMed ID: 9032359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus.
    Huang YH; Tao MH; Hu CP; Syu WJ; Wu JC
    J Gen Virol; 2004 Oct; 85(Pt 10):3089-3098. PubMed ID: 15448372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
    Karimzadeh H; Kiraithe MM; Oberhardt V; Salimi Alizei E; Bockmann J; Schulze Zur Wiesch J; Budeus B; Hoffmann D; Wedemeyer H; Cornberg M; Krawczyk A; Rashidi-Alavijeh J; Rodríguez-Frías F; Casillas R; Buti M; Smedile A; Alavian SM; Heinold A; Emmerich F; Panning M; Gostick E; Price DA; Timm J; Hofmann M; Raziorrouh B; Thimme R; Protzer U; Roggendorf M; Neumann-Haefelin C
    Gastroenterology; 2019 May; 156(6):1820-1833. PubMed ID: 30768983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis D Virus-Specific CD8
    Kefalakes H; Koh C; Sidney J; Amanakis G; Sette A; Heller T; Rehermann B
    Gastroenterology; 2019 May; 156(6):1805-1819.e9. PubMed ID: 30664876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus.
    Shih HH; Shih C; Wang HW; Su CW; Sheen IJ; Wu JC
    J Gen Virol; 2010 Apr; 91(Pt 4):1004-12. PubMed ID: 19940060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo.
    Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ
    J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
    Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
    Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
    Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
    J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
    Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-Based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model.
    Huang YH; Wu JC; Tao MH; Syu WJ; Hsu SC; Chi WK; Chang FY; Lee SD
    Hepatology; 2000 Jul; 32(1):104-10. PubMed ID: 10869296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.
    Villiers MB; Cortay JC; Cortès S; Bloquel B; Brichler S; Brakha C; Kay A; Falah N; Zoulim F; Marquette C; Marche PN; Dény P
    J Clin Microbiol; 2015 Apr; 53(4):1164-71. PubMed ID: 25631795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens.
    Huang YH; Wu JC; Hsu SC; Syu WJ
    J Virol; 2003 Dec; 77(24):12980-5. PubMed ID: 14645554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.